IGM BIOSCIENCES INC (IGMS)
IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firma€ s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymp
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
